Imatinib mesylate in polycythemia vera

This publication has 8 references indexed in Scilit:

• Imatinib mesylate inhibits autonomous erythropoiesis in patients with polycythemia vera in vitro
  Blood, 2003
• Imatinib inhibits the in vitro development of the monocyte/macrophage lineage from normal human bone marrow progenitors
  Leukemia, 2003
• Imatinib mesylate (GleevecTM) reduces phlebotomy requirements in polycythemia vera
  Leukemia, 2003
• Results of imatinib mesylate therapy in patients with refractory or recurrent acute myeloid leukemia, high‐risk myelodysplastic syndrome, and myeloproliferative disorders
  Cancer, 2003
• Polycythemia Vera Responds to Imatinib Mesylate
  The Lancet Healthy Longevity, 2003
• Individual BFU-E in polycythemia vera produce both erythropoietin dependent and independent progeny
  Blood, 1983
• Polycythemia: Mechanisms and Management
  Annals of Internal Medicine, 1981
• Polycythemia Vera: Stem-Cell and Probable Clonal Origin of the Disease
  New England Journal of Medicine, 1976